Dmitri V Baklanov1, Lisa A Kaltenbach2, Steven P Marso1, Sumeet S Subherwal2, Dmitriy N Feldman3, Kirk N Garratt4, Jeptha P Curtis5, John C Messenger6, Sunil V Rao7. 1. Saint Luke's Mid America Heart Institute, Kansas City, Missouri. 2. Duke Clinical Research Institute, Durham, North Carolina. 3. Weill Cornell Medical College, New York Presbyterian Hospital, New York, New York. 4. Northshore-LIJ Lenox Hill Hospital, New York, New York. 5. Yale University School of Medicine, New Haven, Connecticut. 6. University of Colorado School of Medicine, Aurora, Colorado. 7. Duke Clinical Research Institute, Durham, North Carolina. Electronic address: sunil.rao@duke.edu.
Abstract
OBJECTIVES: The purpose of this study was to examine use and describe outcomes of radial access for percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). BACKGROUND: Transradial PCI (TRI) is associated with reduced risk of bleeding and vascular complications, as compared with femoral access PCI (FPCI). Studies have suggested that TRI may reduce mortality among patients with STEMI. METHODS: We examined 294,769 patients undergoing PCI for STEMI at 1,204 hospitals in the CathPCI Registry between 2007 and 2011. Patients were grouped according to access site used for PCI. The temporal trend in the rate of radial versus femoral approach was determined. For minimization of confounding, an inverse probability weighting analysis incorporating propensity scores was used to compare procedural success, post-PCI bleeding, door-to-balloon times, and in-hospital mortality between radial and femoral access. RESULTS: Over the 5-year period, the use of TRI versus FPCI in STEMI increased from 0.9% to 6.4% (p < 0.0001). There was no difference in procedural success. TRI was associated with longer median door-to-balloon time (78 vs. 74 min; p < 0.0001) but lower adjusted risk of bleeding (odds ratio [OR]: 0.62; 95% CI: 0.53 to 0.72; p < 0.0001) and lower adjusted risk of in-hospital mortality (OR: 0.76; 95% CI: 0.57 to 0.99; p = 0.0455). CONCLUSIONS: In this large national database, use of radial access for PCI in STEMI increased over the study period. Despite longer door-to-balloon times, the radial approach was associated with lower bleeding rate and reduced in-hospital mortality. These data provide support to execute an adequately powered randomized controlled trial comparing radial and femoral approaches for PCI in STEMI.
OBJECTIVES: The purpose of this study was to examine use and describe outcomes of radial access for percutaneous coronary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI). BACKGROUND: Transradial PCI (TRI) is associated with reduced risk of bleeding and vascular complications, as compared with femoral access PCI (FPCI). Studies have suggested that TRI may reduce mortality among patients with STEMI. METHODS: We examined 294,769 patients undergoing PCI for STEMI at 1,204 hospitals in the CathPCI Registry between 2007 and 2011. Patients were grouped according to access site used for PCI. The temporal trend in the rate of radial versus femoral approach was determined. For minimization of confounding, an inverse probability weighting analysis incorporating propensity scores was used to compare procedural success, post-PCI bleeding, door-to-balloon times, and in-hospital mortality between radial and femoral access. RESULTS: Over the 5-year period, the use of TRI versus FPCI in STEMI increased from 0.9% to 6.4% (p < 0.0001). There was no difference in procedural success. TRI was associated with longer median door-to-balloon time (78 vs. 74 min; p < 0.0001) but lower adjusted risk of bleeding (odds ratio [OR]: 0.62; 95% CI: 0.53 to 0.72; p < 0.0001) and lower adjusted risk of in-hospital mortality (OR: 0.76; 95% CI: 0.57 to 0.99; p = 0.0455). CONCLUSIONS: In this large national database, use of radial access for PCI in STEMI increased over the study period. Despite longer door-to-balloon times, the radial approach was associated with lower bleeding rate and reduced in-hospital mortality. These data provide support to execute an adequately powered randomized controlled trial comparing radial and femoral approaches for PCI in STEMI.
Authors: R G Brindis; S Fitzgerald; H V Anderson; R E Shaw; W S Weintraub; J F Williams Journal: J Am Coll Cardiol Date: 2001-06-15 Impact factor: 24.094
Authors: Anthony H Gershlick; Amanda Stephens-Lloyd; Sarah Hughes; Keith R Abrams; Suzanne E Stevens; Neal G Uren; Adam de Belder; John Davis; Michael Pitt; Adrian Banning; Andreas Baumbach; Man Fai Shiu; Peter Schofield; Keith D Dawkins; Robert A Henderson; Keith G Oldroyd; Robert Wilcox Journal: N Engl J Med Date: 2005-12-29 Impact factor: 91.245
Authors: M Alan Brookhart; Sebastian Schneeweiss; Kenneth J Rothman; Robert J Glynn; Jerry Avorn; Til Stürmer Journal: Am J Epidemiol Date: 2006-04-19 Impact factor: 4.897
Authors: W S Weintraub; C R McKay; R N Riner; S G Ellis; P L Frommer; D B Carmichael; K E Hammermeister; M N Effros; J E Bost; D P Bodycombe Journal: J Am Coll Cardiol Date: 1997-02 Impact factor: 24.094
Authors: Jung-Won Suh; Roxana Mehran; Bimmer E Claessen; Ke Xu; Usman Baber; George Dangas; Helen Parise; Alexandra J Lansky; Bernhard Witzenbichler; Cindy L Grines; Giulio Guagliumi; Ran Kornowski; Jochen Wöhrle; Dariusz Dudek; Giora Weisz; Gregg W Stone Journal: J Am Coll Cardiol Date: 2011-10-18 Impact factor: 24.094
Authors: Gregg W Stone; Bernhard Witzenbichler; Giulio Guagliumi; Jan Z Peruga; Bruce R Brodie; Dariusz Dudek; Ran Kornowski; Franz Hartmann; Bernard J Gersh; Stuart J Pocock; George Dangas; S Chiu Wong; Ajay J Kirtane; Helen Parise; Roxana Mehran Journal: N Engl J Med Date: 2008-05-22 Impact factor: 91.245
Authors: Neil J Wimmer; David J Cohen; Jason H Wasfy; Saif S Rathore; Laura Mauri; Robert W Yeh Journal: Am Heart J Date: 2014-04-04 Impact factor: 4.749
Authors: Binita Shah; Joseph Burdowski; Yu Guo; Bryan Velez de Villa; Andrew Huynh; Meena Farid; Mansi Maini; Claudia Serrano-Gomez; Cezar Staniloae; Frederick Feit; Michael J Attubato; James Slater; John Coppola Journal: Am J Cardiol Date: 2016-05-28 Impact factor: 2.778
Authors: Kristal Young; Thomas Earl; Faith Selzer; Oscar C Marroquin; Suresh R Mulukutla; Howard A Cohen; David O Williams; Alice Jacobs; Sheryl F Kelsey; J Dawn Abbott Journal: Am J Cardiol Date: 2013-11-23 Impact factor: 2.778
Authors: Ernesto Ruiz-Rodriguez; Ahmed Asfour; Georges Lolay; Khaled M Ziada; Ahmed K Abdel-Latif Journal: South Med J Date: 2016-01 Impact factor: 0.954